Jazz Pharmaceuticals PLC
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.6% | +42.9% | +6.7% | +1.6% | +6.4% | +18.0% | +88.2% | -11.9% | +5.2% | +5.4% | -2.9% | |
| – | +23.8% | -40.5% | +29.4% | +27.4% | +32.1% | +74.2% | -8.0% | -0.2% | +31.8% | +34.7% | -10.0% | |
| – | +44.6% | -63.0% | +5.5% | -19.8% | +105.8% | +66.0% | -44.1% | +49.0% | +70.9% | +60.2% | -42.3% | |
| – | +44.6% | -56.9% | +41.1% | +37.2% | +30.6% | +98.0% | -72.3% | +49.0% | +84.5% | +84.0% | -18.4% | |
| – | +12.5% | +11.7% | -4.3% | +17.7% | +34.9% | +11.4% | +42.1% | +15.6% | +8.3% | +1.6% | +15.9% | |
| – | -35.2% | +75.1% | +27.0% | +22.5% | +48.4% | +21.4% | +1,024.5% | -33.4% | -16.4% | -19.5% | -13.2% | |
| – | +46.6% | +25.6% | +58.2% | +17.8% | +35.2% | -52.8% | +168.4% | -12.2% | – | – | – | |
| – | -6.5% | +36.0% | +6.0% | -2.1% | -0.8% | +4.2% | +90.7% | -7.4% | +3.6% | -2.1% | +6.6% | |
| – | -17.5% | +154.0% | -1.1% | -8.3% | -10.6% | -10.1% | +225.8% | -19.0% | -6.5% | -12.2% | -6.9% | |
| – | -10.5% | +66.0% | -17.5% | +1.5% | -0.7% | +18.5% | +189.7% | -7.0% | -1.2% | +3.4% | -7.3% | |
| – | +4.5% | +13.6% | +14.2% | +17.5% | +5.5% | +79.4% | +23.8% | +15.3% | +64.7% | -32.4% | +115.9% | |
| – | +298.7% | -4.0% | +12.5% | -17.8% | +38.1% | +465.5% | -82.1% | +0.4% | +1,230.3% | -92.7% | +2,181.9% | |
| – | -13.2% | +2.8% | +8.7% | +66.6% | +17.1% | -43.3% | +272.2% | -9.5% | +13.2% | -24.2% | +56.8% | |
| – | -12.5% | +70.8% | -22.7% | +1.5% | +0.7% | +17.5% | +225.6% | -5.4% | -10.3% | +19.0% | -28.8% | |
| – | +16.6% | +17.4% | +44.5% | +1.6% | +12.8% | +17.6% | +8.3% | -22.2% | +21.1% | +9.5% | +5.5% | |
| – | +772.2% | +74.7% | +73.6% | -8.4% | +27.0% | +8.6% | -28.4% | -11.6% | +19.8% | +28.3% | -42.7% | |
| – | +0.7% | -1.8% | -0.9% | -0.2% | -6.0% | -1.8% | +5.6% | +4.8% | +15.2% | -8.4% | -7.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.